CN1220519C - 治疗前列腺癌的中药组合物及其制备方法和制药应用 - Google Patents
治疗前列腺癌的中药组合物及其制备方法和制药应用 Download PDFInfo
- Publication number
- CN1220519C CN1220519C CN02136655.1A CN02136655A CN1220519C CN 1220519 C CN1220519 C CN 1220519C CN 02136655 A CN02136655 A CN 02136655A CN 1220519 C CN1220519 C CN 1220519C
- Authority
- CN
- China
- Prior art keywords
- obtains
- extraction
- water
- extract
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 61
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 206010060862 Prostate cancer Diseases 0.000 title abstract description 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract description 4
- 238000000605 extraction Methods 0.000 claims abstract description 56
- 241000222336 Ganoderma Species 0.000 claims abstract description 26
- 229930013930 alkaloid Natural products 0.000 claims abstract description 23
- 150000003797 alkaloid derivatives Chemical class 0.000 claims abstract description 19
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229930003944 flavone Natural products 0.000 claims abstract description 19
- 235000011949 flavones Nutrition 0.000 claims abstract description 19
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 claims abstract description 18
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 16
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 16
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 14
- 150000004676 glycans Chemical class 0.000 claims abstract description 12
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 12
- 239000005017 polysaccharide Substances 0.000 claims abstract description 12
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 11
- 229930182490 saponin Natural products 0.000 claims abstract description 11
- 150000007949 saponins Chemical class 0.000 claims abstract description 11
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 claims abstract description 10
- 150000002596 lactones Chemical class 0.000 claims abstract description 10
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 claims abstract description 9
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims abstract description 9
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims abstract description 9
- 229960003321 baicalin Drugs 0.000 claims abstract description 9
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 9
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 claims abstract description 9
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 claims abstract description 9
- 235000008718 isoliquiritigenin Nutrition 0.000 claims abstract description 9
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 claims abstract description 7
- 102000002068 Glycopeptides Human genes 0.000 claims abstract description 7
- 108010015899 Glycopeptides Proteins 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 5
- -1 rubescensine A Chemical compound 0.000 claims abstract description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 101
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 99
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 89
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 64
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 64
- 239000007788 liquid Substances 0.000 claims description 64
- 239000000284 extract Substances 0.000 claims description 58
- 229960004756 ethanol Drugs 0.000 claims description 40
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 33
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 28
- 239000000706 filtrate Substances 0.000 claims description 27
- 238000001556 precipitation Methods 0.000 claims description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 21
- 201000001514 prostate carcinoma Diseases 0.000 claims description 20
- 239000003208 petroleum Substances 0.000 claims description 18
- 238000005406 washing Methods 0.000 claims description 18
- 238000002481 ethanol extraction Methods 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 230000002378 acidificating effect Effects 0.000 claims description 15
- 238000002425 crystallisation Methods 0.000 claims description 14
- 230000008025 crystallization Effects 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 13
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 241001646826 Isodon rubescens Species 0.000 claims description 12
- 238000001704 evaporation Methods 0.000 claims description 12
- 230000008020 evaporation Effects 0.000 claims description 12
- 238000011282 treatment Methods 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 10
- 239000003513 alkali Substances 0.000 claims description 9
- 229960000956 coumarin Drugs 0.000 claims description 9
- 235000001671 coumarin Nutrition 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 241000233866 Fungi Species 0.000 claims description 8
- 239000004378 Glycyrrhizin Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 8
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 8
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 8
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 8
- 239000000401 methanolic extract Substances 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 238000004090 dissolution Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- 229920001503 Glucan Polymers 0.000 claims description 6
- 239000004952 Polyamide Substances 0.000 claims description 6
- 239000012043 crude product Substances 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 6
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 6
- 229920002647 polyamide Polymers 0.000 claims description 6
- 238000001953 recrystallisation Methods 0.000 claims description 6
- 239000013049 sediment Substances 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003463 adsorbent Substances 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical compound O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 4
- 238000003808 methanol extraction Methods 0.000 claims description 4
- 239000012452 mother liquor Substances 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- 238000010898 silica gel chromatography Methods 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 244000004005 Nypa fruticans Species 0.000 claims description 3
- 235000005305 Nypa fruticans Nutrition 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 238000005202 decontamination Methods 0.000 claims description 3
- 230000003588 decontaminative effect Effects 0.000 claims description 3
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 3
- 238000011026 diafiltration Methods 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 150000002213 flavones Chemical class 0.000 claims description 3
- 229930182470 glycoside Natural products 0.000 claims description 3
- 150000002338 glycosides Chemical class 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims description 2
- 238000003811 acetone extraction Methods 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims 1
- 229940010454 licorice Drugs 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 241000723353 Chrysanthemum Species 0.000 abstract 2
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 2
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 241001183967 Isodon Species 0.000 abstract 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 abstract 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 abstract 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 description 6
- 239000003163 gonadal steroid hormone Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000207929 Scutellaria Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229960001866 silicon dioxide Drugs 0.000 description 3
- 244000104275 Phoenix dactylifera Species 0.000 description 2
- 235000010659 Phoenix dactylifera Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000035614 depigmentation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229940023462 paste product Drugs 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229920000018 Callose Polymers 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001083505 Punica Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000002681 cryosurgery Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
| 年龄 | 服用本发明中药组合物前的PSA | 服用本发明中药组合物后的PSA |
| 74 | 136.0 | 76(5周) |
| 73 | 308.0 | 233(2周) |
| 52 | 40.6 | 9.0(7周) |
| 73 | 89.0 | 7.12(11周) |
| 65 | 8.3 | 4.9(2个月) |
| 60 | 37 | 15(2个月) |
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN02136655.1A CN1220519C (zh) | 2002-08-26 | 2002-08-26 | 治疗前列腺癌的中药组合物及其制备方法和制药应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN02136655.1A CN1220519C (zh) | 2002-08-26 | 2002-08-26 | 治疗前列腺癌的中药组合物及其制备方法和制药应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1478538A CN1478538A (zh) | 2004-03-03 |
| CN1220519C true CN1220519C (zh) | 2005-09-28 |
Family
ID=34146593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN02136655.1A Expired - Lifetime CN1220519C (zh) | 2002-08-26 | 2002-08-26 | 治疗前列腺癌的中药组合物及其制备方法和制药应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1220519C (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008022505A1 (en) * | 2006-08-18 | 2008-02-28 | Rui Jin Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine | Use of rubescensine a and derivatives thereof in pharmacy |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100446802C (zh) * | 2005-12-27 | 2008-12-31 | 武汉哈福科技有限公司 | 预防肿瘤转移的天然药物 |
| GB0609386D0 (en) * | 2006-05-11 | 2006-06-21 | Active Botan Ltd | Treating drug resistant cancers |
| CN101991681A (zh) * | 2010-11-11 | 2011-03-30 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
| CN104435657B (zh) * | 2013-11-13 | 2018-01-16 | 程惠华 | 一种防治前列腺癌内分泌治疗副作用的药物及其制备方法 |
| CN105106307B (zh) * | 2015-08-10 | 2020-10-20 | 上海中耀生物科技有限公司 | 一种治疗前列腺癌的中药组合物及其制备方法和应用 |
| CN106344830A (zh) * | 2016-10-10 | 2017-01-25 | 南宁多灵生物科技有限公司 | 一种治疗前列腺癌的中药组合物 |
-
2002
- 2002-08-26 CN CN02136655.1A patent/CN1220519C/zh not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008022505A1 (en) * | 2006-08-18 | 2008-02-28 | Rui Jin Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine | Use of rubescensine a and derivatives thereof in pharmacy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1478538A (zh) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1082904A (zh) | 治疗皮肤病的药物组合物 | |
| CN1220519C (zh) | 治疗前列腺癌的中药组合物及其制备方法和制药应用 | |
| CN1220518C (zh) | 抗癌镇痛的中药组合物及其制备方法和制药应用 | |
| CN1200723C (zh) | 白芍甘草提取物及其制备方法 | |
| CN1872282A (zh) | 一种青天葵活性提取物及其制备方法和应用 | |
| CN1628662A (zh) | 具有镇痛作用的药物 | |
| CN1268323C (zh) | 一种圣地红景天软胶囊制剂及其制备方法 | |
| CN1212141C (zh) | 苍术油在制备治疗骨质疏松症药物中的应用 | |
| CN1511583A (zh) | 月季花提取物及其制备方法和用途 | |
| CN100344315C (zh) | 一种促进骨折愈合的药物组合物及其制备方法 | |
| CN1720978A (zh) | 生脉注射制剂及其制备方法 | |
| CN1895302A (zh) | 一种具有抗肿瘤作用的“猕猴桃素”及其制备方法和应用 | |
| CN101040999A (zh) | 一种治疗打鼾的药物组合物及制备方法和质量控制方法 | |
| CN1544032A (zh) | 一种具有抗癌活性的中药提取物和它的制备工艺及其应用 | |
| CN1186351C (zh) | 黄花倒水莲总皂苷及其药物组合物与制备方法 | |
| CN1857654A (zh) | 气管炎制剂及新的制备方法 | |
| CN1634463A (zh) | 治疗糖尿病的药物及生产方法 | |
| CN1323700C (zh) | 一种治疗虚损病的中药组合物及其制备方法和质量标准 | |
| CN1244341C (zh) | 一种治疗子宫内膜异位症的中药组合物及其制备方法 | |
| CN1872199A (zh) | 一种中药组合物及其制备方法 | |
| CN1509729A (zh) | 咽宁搭档 | |
| CN1234253A (zh) | 脾肾两助保健饮料 | |
| CN1586600A (zh) | 藏药独一味注射制剂及其制备方法 | |
| CN1263490C (zh) | 一种助阳药及其制备方法 | |
| CN100342878C (zh) | 一种消炎、止咳、化痰的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160125 Address after: 200126, room 8, No. 190, Lane 1802, Changli Road, Pudong New Area, Shanghai Patentee after: Yang Qiliang Address before: 201802 No. 4278 South Main Road, Shanghai, 5-150 Patentee before: SHANGHAI ZHONGYAO BIO-TECHNOLOGY Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190807 Address after: Room 119, Building 333 Cailun Road, China (Shanghai) Free Trade Pilot Area, Pudong New Area, Shanghai, 201203 Patentee after: SHANGHAI ZHONGYAO BIO-TECHNOLOGY Co.,Ltd. Address before: 200126, room 8, No. 190, Lane 1802, Changli Road, Pudong New Area, Shanghai Patentee before: Yang Qiliang |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20050928 |